How Harvard Business School is Accelerating Precision Medicine

by Kathy Giusti and Richard G. Hamermesh

Accelerating Precision Medicine – We, the authors, are not scientists or researchers and don’t operate a lab or an incubator. We are businesspeople, entrepreneurs, and system thinkers with broad experience in areas such as finance, marketing, and operations.

Our mission is not to bring one specific drug to market faster. It is to act as a catalyst that accelerates the entire precision medicine ecosystem by connecting people, changing business processes, and disseminating best practices.

Previous Article Back to Writing Next Article